Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Nasal splint may improve tear duct surgery success

NCT ID NCT07605026

Disease control Sponsor: Kafrelsheikh University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at 150 adults with blocked tear ducts who had a surgery called endoscopic DCR. Half received an internal nasal splint during the procedure, and half did not. The goal was to see if the splint helped keep the new tear duct opening clear and reduced scarring. Researchers measured success by how well tears drained and whether complications like synechia (tissue sticking together) occurred.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
internal nasal splint
What this could lead to
If successful, using an internal nasal splint during DCR surgery could reduce scarring and improve tear duct function, leading to better outcomes for patients with blocked tear ducts.
What could go wrong
This is a completed study with 150 participants, but it compares two surgical techniques rather than testing a new drug or treatment. The results may not apply to all patients or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

150 people

The number who actually took part.

Started

Jan 2024

Finished

Jul 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age \>18 years. Symptomatic NLDO (epiphora, recurrent dacryocystitis). Fit for general anesthesia Exclusion Criteria: * Congenital dacryocystitis. Canalicular or punctal obstruction. Previous lacrimal surgery. Post-traumatic or post-radiation epiphora. Coexisting nasal pathology (tumors, granulomatous disease, atrophic rhinitis). Immunocompromised or uncontrolled systemic disease. Patients unwilling to undergo endoscopic surgery.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Nasolacrimal duct obstruction are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

familial congenital nasolacrimal duct obstruction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Synechia after DCR

Contacts and locations

Locations

  • Kafrelsheikh University Hospitals

    Kafrelsheikh, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.